Javascript must be enabled to continue!
Intubating Conditions with three different doses of Rocuronium in surgery of cancer patients
View through CrossRef
Background: This is a prospective randomized, double blind study to determine the doses of rocuronium that would give 90% and 95% probabilities of successful tracheal intubation within 60s after administration. This study evaluated intubating conditions and duration of action of 0.4 mg, 0.8 mg and 1.2 mg of rocuronium, administered intravenously in patients undergoing elective surgical procedures. Goal in this study is to define doses level of rocuronium that would provide optimal relaxation for tracheal intubation in patients in whom succinylcholine was relatively contraindicated.
Methods: Sixty patients both male and female, ASA I & II, age between 18–60 years, with BMI of less that 30 who were planned for elective surgical procedures were randomized into three groups. Group A received 0.4 mg (n=20), Group B received 0.8 mg (n=20) and Group C received 1.2 mg (n=20) of rocuronium. At 60 seconds after injection of the rocuronium, laryngoscopy was initiated, with the goal being endotracheal tube passed through the patient's vocal cords and the cuff inflated within the trachea in 20s. Intubating conditions was graded excellent, good or poor according to Cooper scoring system criteria. When the patient lost consciousness, train-of-four (TOF) stimulation (at 2 Hz and repeated every 12s) were recorded. Immediately after tracheal intubation and every 5 min thereafter the investigator counted the number of tactile TOF responses. The duration of action of rocuronium was defined as the time from the end of injection of rocuronium until reappearance of first tactile response to TOF stimulation.
Results: There were twelve patients in the 0.4mg/kg rocuronium group, two in the 0.8mg/kg group, and one in the 1.2mg/kg rocuronium group with an unacceptable intubation grade caused by sustained coughing at intubation. The D90 and D95 doses were 0.83(0.59 -1.03) and 1.04 (0.76-1.36) mg/kg, respectively. Estimated time until first tactile train-of-four response after D50 and D95 doses were 43min and 52 min, respectively.
Conclusion: After induction with pethedine and sodium thiopentone, rocuronium in a dose of 0.8mg/kg produces equivalent intubating conditions as that of 1.2mg/kg after 60 seconds of administration
Title: Intubating Conditions with three different doses of Rocuronium in surgery of cancer patients
Description:
Background: This is a prospective randomized, double blind study to determine the doses of rocuronium that would give 90% and 95% probabilities of successful tracheal intubation within 60s after administration.
This study evaluated intubating conditions and duration of action of 0.
4 mg, 0.
8 mg and 1.
2 mg of rocuronium, administered intravenously in patients undergoing elective surgical procedures.
Goal in this study is to define doses level of rocuronium that would provide optimal relaxation for tracheal intubation in patients in whom succinylcholine was relatively contraindicated.
Methods: Sixty patients both male and female, ASA I & II, age between 18–60 years, with BMI of less that 30 who were planned for elective surgical procedures were randomized into three groups.
Group A received 0.
4 mg (n=20), Group B received 0.
8 mg (n=20) and Group C received 1.
2 mg (n=20) of rocuronium.
At 60 seconds after injection of the rocuronium, laryngoscopy was initiated, with the goal being endotracheal tube passed through the patient's vocal cords and the cuff inflated within the trachea in 20s.
Intubating conditions was graded excellent, good or poor according to Cooper scoring system criteria.
When the patient lost consciousness, train-of-four (TOF) stimulation (at 2 Hz and repeated every 12s) were recorded.
Immediately after tracheal intubation and every 5 min thereafter the investigator counted the number of tactile TOF responses.
The duration of action of rocuronium was defined as the time from the end of injection of rocuronium until reappearance of first tactile response to TOF stimulation.
Results: There were twelve patients in the 0.
4mg/kg rocuronium group, two in the 0.
8mg/kg group, and one in the 1.
2mg/kg rocuronium group with an unacceptable intubation grade caused by sustained coughing at intubation.
The D90 and D95 doses were 0.
83(0.
59 -1.
03) and 1.
04 (0.
76-1.
36) mg/kg, respectively.
Estimated time until first tactile train-of-four response after D50 and D95 doses were 43min and 52 min, respectively.
Conclusion: After induction with pethedine and sodium thiopentone, rocuronium in a dose of 0.
8mg/kg produces equivalent intubating conditions as that of 1.
2mg/kg after 60 seconds of administration.
Related Results
Rocuronium for intubation in parturients undergoing caesarean section
Rocuronium for intubation in parturients undergoing caesarean section
Background: Anaesthetic management of a parturient is a challenge because it involves simultaneous care of both mother and baby. Succinylcholine, a depolarizing muscle relaxant is ...
ROCURONIUM VERSUS CISATRACURIUM: INTUBATING CONDITIONS, EFFICACY, AND SAFETY.
ROCURONIUM VERSUS CISATRACURIUM: INTUBATING CONDITIONS, EFFICACY, AND SAFETY.
Background: Neuromuscular blockers (NMB) are very important adjuvant to general anesthesia,Rocuronium bromide
(aminosteroidal NMB) and cisatracurium besylate (benzylisoquinoline NM...
Randomized prospective study to compare intubating conditions with cisatracurium or rocuronium using train-of-four neuromuscular monitoring in adult patients undergoing elective surgery
Randomized prospective study to compare intubating conditions with cisatracurium or rocuronium using train-of-four neuromuscular monitoring in adult patients undergoing elective surgery
Background: Nondepolarizing skeletal muscle relaxants are used in anesthesia to ease endotracheal intubation and improve ventilation. Monitoring neuromuscular blockade is crucial t...
The Association Between Intraoperative Objective Neuromuscular Monitoring and Rocuronium Consumption During Laparoscopic Abdominal Surgery: A Single-Center Retrospective Analysis
The Association Between Intraoperative Objective Neuromuscular Monitoring and Rocuronium Consumption During Laparoscopic Abdominal Surgery: A Single-Center Retrospective Analysis
Abstract
Background: Rocuronium consumption with or without intraoperative objective neuromuscular monitoring in clinical settings of unrestricted use of sugammadex and neu...
Intubating Conditions and First Pass Success Rate with Low Dose Rocuronium during Rapid Sequence Intubation: A Cross-sectional Study
Intubating Conditions and First Pass Success Rate with Low Dose Rocuronium during Rapid Sequence Intubation: A Cross-sectional Study
Introduction: Emergency Rapid Sequence Intubation (RSI) aims to reduce complications such as pulmonary aspiration, prolonged intubation with hypoxia and the occurrence of a crash a...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Analysis of onset time and intubating conditions following intravenous administration of Rocuronium 0.6mg/kg and Rocuronium 0.9mg/kg doses and its comparison with Succinylcholine 1.5mg/kg for Rapid Sequence Induction
Analysis of onset time and intubating conditions following intravenous administration of Rocuronium 0.6mg/kg and Rocuronium 0.9mg/kg doses and its comparison with Succinylcholine 1.5mg/kg for Rapid Sequence Induction
Background: The purpose of this study was to compare rocuronium to succinylcholine in adult patients undergoing elective surgery using two different doses of 0.6 mg/kg and 0.9 mg/k...
Study of Efficacy of Sevoflurane with Rocuronium during Induction in Neurosurgical Patients
Study of Efficacy of Sevoflurane with Rocuronium during Induction in Neurosurgical Patients
Background: Rocuronium provides good intubating conditions but large doses causes prolongation of its duration of action, making it unsuitable for short surgical procedures. Aims: ...

